SandboxAQ brings its drug discovery models to Claude — no PhD in computing required
TL;DR
Other venture-backed companies like Chai Discovery and Isomorphic Labs are racing to build better drug discovery models. SandboxAQ is betting that access is the bigger obstacle — and that hooking its models directly into Claude is what unlocks it for non-specialists.
Nauti's Take
Real opportunity: SandboxAQ is breaking open access to drug discovery — researchers without a computing PhD can now use the models straight from Claude. That lowers the barrier and could meaningfully speed up early-stage hit-finding.
The catch: model quality and lab validation still decide whether the suggestions hold up — trust in chat output cannot become trust in unvalidated leads. Smaller biotech teams that lacked compute know-how are the ones who stand to gain most.
Sources